Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national

Elizabeth V Arkema1, Ronald F van Vollenhoven, Johan Askling

  • 1Clinical Epidemiology Unit (T2), Department of Medicine, Karolinska Institutet, Stockholm SE-171 76, Sweden. earkema@post.harvard.edu

Abstract

Insights

Patients with rheumatoid arthritis (RA) may face a higher risk of progressive multifocal leukoencephalopathy (PML) compared to the general population. This study investigated PML incidence in RA patients, with or without biological agent exposure.

Area of Science:

  • Rheumatology
  • Neurology
  • Epidemiology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare but serious disease.
  • PML cases have been reported in rheumatoid arthritis (RA) patients on biological therapy.
  • Limited data exists on PML incidence in RA patients without biological agent exposure.

Purpose of the Study:

  • To estimate the incidence rate of PML in RA patients.
  • To compare PML incidence in RA patients versus the general population.
  • To assess PML incidence with and without exposure to biological agents.

Main Methods:

  • Utilized Swedish national registries from 1999-2009.
  • Included adult-onset RA patients diagnosed with PML and biological agent exposure.
  • Matched RA patients with general population comparators by age, sex, and county.
  • Calculated crude and standardized incidence rates per 100,000 person-years.

Main Results:

  • The study included 66,278 RA patients and 286,949 general population comparators.
  • PML incidence rate in RA patients was 1.0 (95% CI 0.3 to 2.5) vs. 0.3 (95% CI 0.1 to 0.6) in the general population.
  • Only one PML case was identified among patients exposed to biological agents.

Conclusions:

  • RA patients may have an increased rate of PML compared to the general population.
  • Further research is needed to understand the specific risks and mechanisms involved.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...